22nd Apr 2005 12:08
Sinclair Pharma PLC22 April 2005 Sinclair Pharma plc ("Sinclair" or the "Company") In order to satisfy institutional demand and improve liquidity in the Company'sordinary shares ("Ordinary Shares") the following directors yesterday sold anaggregate of 3,800,000 Ordinary Shares, as detailed below: Director No. of Shares Sold Price % ISC Michael Flynn 2,000,000 125.0p 3.6%Jerry Randall 800,000 125.0p 1.4%Andrew Sinclair 1,000,000 125.0p 1.8% Following the sale of these Ordinary Shares, the directors' interest in theCompany, including their interest in Ordinary Shares under the Sinclair employeeshare trust (all of which can be exercised at any date up until 2 December2013), is as follows: Ordinary Shares No. of Ordinary held under employeeDirector Shares held share trust Total % ISC Michael Flynn 9,169,300 3,448,500 12,617,800 22.5%Jerry Randall 385,000 2,551,890 2,936,890 5.2%Andrew Sinclair 5,045,000 0 5,045,000 9.0% This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma